Diabetes treatment is constantly evolving, with new therapeutic options appearing to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the https://tamzinqtpt141023.onesmablog.com/novel-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment-80082812